TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
PMVP

Pmv Pharmaceuticals Inc

Healthcare · Biotechnology

1.30$ -1.2% vs. previous close Closing price · As of: Nov 6, 2026

Ownership

Ownership Structure

Who owns Pmv Pharmaceuticals Inc (PMVP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 57.3% of the shares are freely tradable; institutional investors hold 69.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 69.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 3.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 57.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 76Mio.

Largest Shareholders

Institutions

Institutions PMVP
Name Stake (%) Shares Change (%) Date
BML Capital Management LLC 7.06 5,330,000 +0.2 06/30/2026
TANG CAPITAL MANAGEMENT LLC 5.62 4,245,085 +0.0 06/30/2026
Sio Capital Management, LLC 3.49 2,634,137 -14.4 06/30/2026
Euclidean Capital LLC 3.48 2,627,643 +0.0 06/30/2026
Adage Capital Partners Gp LLC 3.13 2,360,000 +26.9 06/30/2026
Acadian Asset Management LLC 2.93 2,215,894 +0.0 06/30/2026
Vanguard Capital Management, LLC 2.66 2,012,020 +1.9 06/30/2026
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 2.60 1,959,579 -31.8 06/30/2026
Two Sigma Investments LLC 2.59 1,954,136 +3.7 06/30/2026

Funds

Funds PMVP
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 3.16 2,384,501 +60.3 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?